Xiaofen Liu

4.6k total citations · 2 hit papers
175 papers, 3.4k citations indexed

About

Xiaofen Liu is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, Xiaofen Liu has authored 175 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Medicine, 31 papers in Pharmacology and 27 papers in Molecular Biology. Recurrent topics in Xiaofen Liu's work include Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Quantum Computing Algorithms and Architecture (17 papers). Xiaofen Liu is often cited by papers focused on Antibiotic Resistance in Bacteria (33 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Quantum Computing Algorithms and Architecture (17 papers). Xiaofen Liu collaborates with scholars based in China, United States and Australia. Xiaofen Liu's co-authors include Eric M. Reiman, Kewei Chen, Wendy Lee, Napatkamon Ayutyanont, Song Lin, Jessica B. Langbaum, Richard J. Caselli, Gene E. Alexander, Daniel Bandy and Adam Fleisher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaofen Liu

160 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

2009 618 citations Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences profile →
Antimicrobial resistance crisis: could artificial intelligence be the solution?

2024 48 citations Xiaofen Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaofen Liu China	28	1.2k	876	771	350	315	175	3.4k
Chunping Zhang China	38	578 0.5×	103 0.1×	1.1k 1.4×	43 0.1×	216 0.7×	265	4.7k
Zhen Li China	42	457 0.4×	105 0.1×	2.0k 2.6×	97 0.3×	276 0.9×	373	6.0k
Matthias Kohl Germany	40	1.2k 1.0×	193 0.2×	906 1.2×	501 1.4×	232 0.7×	210	6.2k
Shin�ichi Yoshida Japan	46	528 0.5×	92 0.1×	2.1k 2.8×	122 0.3×	185 0.6×	252	6.7k
Satoshi Imai Japan	37	991 0.9×	120 0.1×	1.7k 2.2×	196 0.6×	433 1.4×	236	5.0k
Sun Ho Kim South Korea	42	2.7k 2.3×	94 0.1×	1.8k 2.3×	163 0.5×	665 2.1×	323	8.5k
Ran Zhang China	34	653 0.6×	74 0.1×	2.0k 2.6×	138 0.4×	244 0.8×	334	4.8k
Ramón González United States	61	525 0.5×	680 0.8×	2.6k 3.4×	767 2.2×	318 1.0×	242	12.2k
Maree T. Smith Australia	45	2.4k 2.0×	439 0.5×	1.5k 2.0×	255 0.7×	890 2.8×	211	7.6k
Mahendra Patel United States	31	151 0.1×	418 0.5×	563 0.7×	362 1.0×	178 0.6×	113	3.3k

Countries citing papers authored by Xiaofen Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaofen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofen Liu more than expected).

Fields of papers citing papers by Xiaofen Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofen Liu. The network helps show where Xiaofen Liu may publish in the future.

Co-authorship network of co-authors of Xiaofen Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofen Liu. A scholar is included among the top collaborators of Xiaofen Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofen Liu. Xiaofen Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wei, Zhiwei Ren, Lifeng Zhang, et al.. (2025). Promoting in-situ stability of hydroxide exchange membranes by thermally conductive network for durable water electrolysis. Nature Communications. 16(1). 934–934. 7 indexed citations

Huang, Xiaolan, Xiaofen Liu, Yaxin Fan, et al.. (2024). Pharmacokinetics and safety of colistin sulfate after single and multiple intravenous doses in healthy Chinese subjects. International Journal of Antimicrobial Agents. 64(5). 107326–107326. 1 indexed citations

Zhu, Yu Cheng, et al.. (2024). Microarray and Functional Pathway Analyses Revealed Significantly Elevated Gene Expressions Associated with Metabolic Resistance to Oxamyl (Vydate) in Lygus lineolaris. Toxics. 12(3). 188–188. 1 indexed citations

Li, Yi, Jufang Wu, Jicheng Yu, et al.. (2023). Population pharmacokinetics and exposure-safety of lipophilic conjugates prodrug DP-VPA in healthy Chinese subjects for dose regime exploring. European Journal of Pharmaceutics and Biopharmaceutics. 188. 153–160. 1 indexed citations

Li, Yi, Kaoru Toyama, Hitoshi Ishizuka, et al.. (2023). Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study. Advances in Therapy. 40(4). 1628–1643. 4 indexed citations

Chen, Yuancheng, Jiali Hu, Xiaolan Huang, et al.. (2022). Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model. Molecules. 27(3). 1085–1085. 7 indexed citations

Liu, Xiaofen, Fupin Hu, Meiqing Feng, et al.. (2022). Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens. Frontiers in Pharmacology. 12. 785893–785893. 8 indexed citations

Liu, Xiaofen, Wenjuan Zhang, Changbin Jing, et al.. (2021). Mutation of Gemin5 Causes Defective Hematopoietic Stem/Progenitor Cells Proliferation in Zebrafish Embryonic Hematopoiesis. Frontiers in Cell and Developmental Biology. 9. 670654–670654. 8 indexed citations

Liu, Xiaofen, Yanan Liu, Fuchang Zhang, et al.. (2020). Genetic Variants of the MTMR 9 Gene Are Associated with Nonspecific Intellectual Disability: A Family-Based Association Study. Genetic Testing and Molecular Biomarkers. 24(10). 625–631.

10.

Liu, Xiaofen, Meiqing Feng, Phillip J. Bergen, et al.. (2020). Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii. International Journal of Antimicrobial Agents. 57(2). 106271–106271. 20 indexed citations

11.

Yang, Rui, Qiang Jia, Xiaofen Liu, et al.. (2016). [Effect of hydrogen sulfide on oxidative stress and endoplasmic reticulum stress in diabetic cardiomyopathy].. PubMed. 32(1). 8–12. 10 indexed citations

12.

Sun, Kexin, Zhike Liu, Yaying Cao, et al.. (2015). [Relationship between brachial-ankle pulse wave velocity and glycemic control of type 2 diabetes mellitus patients in Beijing community population].. PubMed. 47(3). 431–6. 2 indexed citations

13.

Liu, Xiaofen. (2014). Performance Evaluation of Higher Education Expenditure of Brazil: Principles,Index System, Method and Application. 1 indexed citations

14.

Liu, Xiaofen. (2013). Study on the Connotation and the Status of Emotional Management.

15.

Liu, Xiaofen, et al.. (2012). Multiparty Quantum Secret Sharing Protocol with Authentication. Journal of Chinese Computer Systems. 33(11). 2518–2521. 1 indexed citations

16.

Langbaum, Jessica B., Kewei Chen, Lenore J. Launer, et al.. (2011). Blood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age persons. Neurobiology of Aging. 33(4). 827.e11–827.e19. 103 indexed citations

17.

Liu, Xiaofen, et al.. (2010). 誘導体化に続くLC-MS/MSによる血漿中のgestodene,etonogestrel,およびethinylestradiolの同時定量. 45(1). 87–92. 1 indexed citations

18.

Wu, Xia, Kewei Chen, Li Yao, et al.. (2010). Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment. Journal of Neuroscience Methods. 192(2). 277–285. 13 indexed citations

19.

Reiman, Eric M., Kewei Chen, Xiaofen Liu, et al.. (2009). Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences. 106(16). 6820–6825. 618 indexed citations breakdown →

20.

Kubo, Takekazu, Robin D. Hatton, James R. Oliver, et al.. (2004). Regulatory T Cell Suppression and Anergy Are Differentially Regulated by Proinflammatory Cytokines Produced by TLR-Activated Dendritic Cells. The Journal of Immunology. 173(12). 7249–7258. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact